Search results for "Enos"

showing 10 items of 1576 documents

Review and update on drugs related to the development of osteonecrosis of the jaw

2019

Conflict of interest Conclusions of the working group on “New drugs related to the de-velopment of osteonecrosis of the jaw”. Spanish Society of Cranio-mandibular Dysfunction and Orofacial Pain and Spanish Society of Oral Medicine SEDCYDO-SEMO joint International Meeting: 30th SEDCYDO annual meeting & 15th SEMO Congress. Bilbao (Spain); June, 2019. [EN] Background: Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but serious adverse effect of cer-tain drugs, of which bisphosphonates are the most widely known. This pathology is also associated with other medications such as the biologic antiresorptive agent, denosumab and some antiangiogenics such as sunitinib, bevacizumab or a…

medicine.medical_specialtyBevacizumabReviewMRONJ03 medical and health sciencesantiresorptives0302 clinical medicinemedicineHumansIntensive care medicineAdverse effectGeneral DentistrybisphosphonatesAfliberceptBisphosphonate-associated osteonecrosis of the jawOral Medicine and PathologyBone Density Conservation AgentsDiphosphonatesbusiness.industrySunitinibOsteonecrosis030206 dentistryEvidence-based medicinemedicine.disease:CIENCIAS MÉDICAS [UNESCO]osteonecrosis of the jawantiangiogenicsDenosumabOtorhinolaryngologyPharmaceutical PreparationsUNESCO::CIENCIAS MÉDICASSurgeryBisphosphonate-Associated Osteonecrosis of the JawDenosumabbusinessOsteonecrosis of the jawmedicine.drug
researchProduct

New paradigms for dental prevention of medication related osteonecrosis of jaws (MRONJ)

2018

ONJ-Prevention of local osteonecrosis risk factors should be planned before and during the intake of associated drugs, according to new schedules. Secondary prevention requires a careful clinical oral examination, but also first level X-ray examinations and, when necessary, second level (CT) too. Three main risk factors of ostonecrosis of the jaws (ONJ) are recognised: (i) the type of ONJ-related medications: antiresorptive (e.g., Bisphosphonates, Denosumab) and antiangiogenic drugs (e.g., Bevacizumab, Sunitinib); (ii) the category of patient at MRONJ risk: cancer versus non-cancer patient; (iii) the typologies and timing of dental treatments (e.g., before, during, or after the drug adminis…

medicine.medical_specialtyBevacizumabbusiness.industrySunitinibGeneral EngineeringCancermedicine.diseaseDenosumabInternal medicineOral and maxillofacial pathologyMedicineOral examinationIn patientbusinessOsteonecrosis of the jawmedicine.drugQeios
researchProduct

Classification of coronary artery bifurcation lesions and treatments: time for a consensus

2008

Background: Percutaneous coronary intervention (PCI) of coronary bifurcation lesions remains a subject of debate. Many studies have been published in this setting. They are often small scale and display methodological flaws and other shortcomings such as inaccurate designation of lesions, heterogeneity, and inadequate description of techniques implemented. Methods: The aim is to propose a consensus established by the European Bifurcation Club (EBC), on the definition and classification of bifurcation lesions and treatments implemented with the purpose of allowing comparisons between techniques in various anatomical and clinical settings. Results: A bifurcation lesion is a coronary artery na…

medicine.medical_specialtyBifurcation lesionmedicine.medical_treatmentCoronary AngiographyLesionProsthesis Implantationbifurcation lesionsAngioplastyTerminology as TopicmedicineHumansRadiology Nuclear Medicine and imagingclassification of bifurcation lesionsAngioplasty Balloon CoronaryClassification of bifurcation lesionBifurcationQCA.QCAbusiness.industryCoronary StenosisPercutaneous coronary interventionStentGeneral MedicineClassification of treatmentmedicine.anatomical_structureHomogeneousConventional PCISettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREStentsRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessArtery
researchProduct

Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw

2014

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious complication associated with oral and intravenous bisphosphonate therapy that adversely affects the quality of life, producing significant morbidity. Since the first description of bone necrosis in patients receiving bisphosphonate therapy in 2003 [1], hundreds of studies were published about this topic and various national and international medical societies have published protocols and guidelines. Nevertheless, there are still many controversies regarding the classification, management, and prevention of BRONJ. Even the definition of BRONJ is still debated and changed with the progress of knowledge and experience. Accord…

medicine.medical_specialtyBisphosphonate-associated osteonecrosis of the jawArticle Subjectbusiness.industrymedicine.medical_treatmentRetrospective cohort studyBisphosphonatemedicine.diseaseReview articleSurgeryBisphosphonate Osteonecrosis of the Jawlcsh:RK1-715EditorialDenosumablcsh:DentistryOral and maxillofacial pathologymedicineOral and maxillofacial surgeryIntensive care medicineOsteonecrosis of the jawbusinessGeneral Dentistrymedicine.drugInternational Journal of Dentistry
researchProduct

Myocardial blood flow quantification for evaluation of coronary artery disease by computed tomography

2017

During the last decade coronary computed tomography angiography (CTA) has become the preeminent non-invasive imaging modality to detect coronary artery disease (CAD) with high accuracy. However, CTA has a limited value in assessing the hemodynamic significance of a given stenosis due to a modest specificity and positive predictive value. In recent years, different CT techniques for detecting myocardial ischemia have emerged, such as CT-derived fractional flow reserve (FFR-CT), transluminal attenuation gradient (TAG), and myocardial CT perfusion (CTP) imaging. Myocardial CTP imaging can be performed with a single static scan during first pass of the contrast agent, with monoenergetic or dual…

medicine.medical_specialtyCardiac computed tomographyMyocardial blood flow quantificationPerfusion scanningFractional flow reserveReview Article030204 cardiovascular system & hematology030218 nuclear medicine & medical imagingCoronary artery disease03 medical and health sciencesMyocardial perfusion imaging0302 clinical medicineStress imagingInternal medicinemedicinemedicine.diagnostic_testbusiness.industryMyocardial perfusion imagingmedicine.diseaseRegadenosonDipyridamoleCoronary artery disease (CAD)StenosisCardiologyRadiologyCoronary vasodilatorbusinessCardiology and Cardiovascular MedicineSettore MED/36 - Diagnostica Per Immagini E Radioterapiamedicine.drug
researchProduct

Predictors of carotid artery in-stent restenosis

2012

SummaryBackgroundCarotid angioplasty and stenting (CAS) is increasingly being used as a treatment alternative to endarterectomy (CEA), especially in patients aged <70 years with significant carotid artery stenosis. However, an in-stent restenosis (ISR) might endangering the long-term efficacy of CAS. The aim of this article was to review the current literature regarding incidence and clinical significance as well as predictors of in-stent restenosis.MethodsWe conducted a systematic review of the literature to identify all studies on the abovementioned factors.Results3 randomized-controlled trials comparing CAS and CEA and 13 single centre studies fulfilled our inclusion criteria. The occurr…

medicine.medical_specialtyCarotid arteriesmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRestenosisAngioplastyStentMedicineClinical significanceCarotid artery stenosis10. No inequalityStrokeEndarterectomyRestenosisbusiness.industryAngioplastyStentGeneral Medicinemedicine.disease3. Good healthStrokeRadiologyIn stent restenosisCarotid ultrasoundbusiness030217 neurology & neurosurgeryPerspectives in Medicine
researchProduct

The use of a proximal protection system, a reperfusion catheter, and new-generation mesh stents in combined endovascular therapy for a long, symptoma…

2020

medicine.medical_specialtyCathetersbusiness.industryDissectionEndovascular ProceduresDissection (medical)Surgical Meshmedicine.diseaseEndovascular therapySystem aSurgeryProximal protectionCatheterTreatment OutcomeRight internal carotid arteryReperfusionMedicineHumansCarotid StenosisStentsCardiology and Cardiovascular MedicinebusinessCarotid Artery InternalKardiologia polska
researchProduct

Endovascular management of carotid and vertebral artery dissections with new generation double-mesh stent and protection systems – single-center earl…

2019

Introduction Symptomatic dissections (SD) of cervical arteries are still a therapeutic problem. Although endovascular management (EM) is currently a preferred method of treatment of SD, complications associated with this method of treatment in published reports are quite frequent (3-16%). Aim In this retrospective study we analyzed the results of EM with novel, double-mesh stent and protection systems (PS) for SD of the internal carotid (IC) or vertebral arteries (VA) that coexisted with hemodynamically significant stenosis or aneurysmatic dilatation of the dissected artery. Material and methods We evaluated the results of EM in 19 patients (men 15, median age: 55, range: 25-83), presenting…

medicine.medical_specialtyCervical Arterymedicine.medical_treatmentVertebral arterylcsh:MedicineHorner syndrome030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineAneurysmmedicine.arterymedicineprotection systemOriginal Paperbusiness.industrycarotid arterylcsh:RStentdouble-mesh stentmedicine.diseaseSurgeryStenosisDissectionmedicine.anatomical_structuredissectionCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryArteryPostepy w Kardiologii Interwencyjnej
researchProduct

Flegmasia cerulea dolens en paciente con carcinoma testicular

2006

Describimos un caso de flegmasia cerulea dolens secundaria a una trombosis venosa profunda por compresión de la vena cava inferior, en un varón de 31 años con un tumor germinal. Necesitó un tratamiento urgente con agentes fibrinolíticos, heparina intravenosa y quimioterapia. Con el tratamiento obtuvo una respuesta completa tumoral y una completa revascularización de la vena cava y vena femoral derecha.

medicine.medical_specialtyChemotherapybusiness.industryUrologymedicine.medical_treatmentFemoral veinFlegmasia cerulea dolensThrombolysismedicine.diseaseRevascularizationInferior vena cavaSurgeryVenous thrombosisTumor germinalmedicine.veinTrombosis venosacardiovascular systemMedicinecardiovascular diseasesRadiologybusinessGerm cell tumourTrombolisisPhlegmasia cerulea dolensActas Urológicas Españolas
researchProduct

The stomach in liver cirrhosis

1991

Abstract The stomachs of cirrhotic patients are frequently subject to a number of alterations, detectable by endoscopy, the presence of which indicates a disturbance in the mucosa. Several investigators believe that portal hypertension plays an etiopathogenetic role. Three groups of subjects were studied prospectively: 83 cirrhotic patients with portal hypertension, 53 cirrhotic patients without portal hypertension, and 135 control subjects. Snake skin, scarlatina rash, and petechia were the most frequent endoscopic findings in the cirrhotic patients with portal hypertension ( P

medicine.medical_specialtyCirrhosisHepatologymedicine.diagnostic_testbusiness.industryEsophagogastroduodenoscopyStomachGastroenterologymedicine.diseaseControl subjectsGastroenterologyRashEndoscopymedicine.anatomical_structureInternal medicineMedicinePortal hypertensionmedicine.symptomPetechiabusinessGastroenterology
researchProduct